AR and breast neoplasm: A majority (~70%) of breast tumors are estrogen receptor positive, and a significant portion (~90%) of ER-positive (ER+) breast tumors are also androgen receptor-positive (AR+) which is found to be predominantly expressed in in-situ, invasive, and metastatic breast cancers (4).